ADAPY
Adaptimmune Therapeutics Plc - ADR

9,690
Mkt Cap
$6.89M
Volume
319,019.00
52W High
$0.6198
52W Low
$0.0009
PE Ratio
-0.04
ADAPY Fundamentals
Price
$0.03
Prev Close
$0.026
Open
$0.03
50D MA
$0.0346
Beta
0.94
Avg. Volume
1.39M
EPS (Annual)
-$0.2808
P/B
-0.10
Rev/Employee
$351,989.95
$58.52
Loading...
Loading...
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
506

Frequently Asked Questions

What is Market Cap of Adaptimmune Therapeutics Plc - ADR?
What is the 52-week high for Adaptimmune Therapeutics Plc - ADR?
What is the 52-week low for Adaptimmune Therapeutics Plc - ADR?
What is Adaptimmune Therapeutics Plc - ADR stock price today?
What was Adaptimmune Therapeutics Plc - ADR stock price yesterday?
What is the PE ratio of Adaptimmune Therapeutics Plc - ADR?
What is the Price-to-Book ratio of Adaptimmune Therapeutics Plc - ADR?
What is the 50-day moving average of Adaptimmune Therapeutics Plc - ADR?
How many employees does Adaptimmune Therapeutics Plc - ADR have?

Latest ADAPY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.